Brief: Silo Pharma Signs Agreement To Develop Ketamine Implant Therapeutic
13/06/2023 14:32
June 13 (Reuters) - Silo Pharma Inc SILO.O :
* SILO PHARMA SIGNS AGREEMENT TO DEVELOP FIRST-IN-CLASS
KETAMINE
IMPLANT THERAPEUTIC
Source text for Eikon: ID:nGNX4F4r62
Further company coverage: SILO.O
(reuters.briefs@thomsonreuters.com)
Recent news on Silo Pharma
See all newsBrief: Silo Pharma - Enters Asset Purchase Agreement With Larry King On October 13, 2026 - SEC Filing
Brief: Silo Pharma Enters Asset Purchase Agreement With Norsight Consulting On Oct 1 - SEC Filing
Brief: Silo Pharma Enters Asset Purchase Agreement With Parkview Consulting
Brief: Silo Pharma Selling Shareholders Offer On Resale Basis 1.9 Million Shares Of Silo Pharma Common Stock - SEC Filing
Brief: Silo Pharma Regains Compliance With Nasdaq Minimum Bid Price Requirement